NAFLD independently linked to cardiovascular disease

NAFLD independently linked to cardiovascular disease
Nonalcoholic fatty liver disease is independently associated with an increased risk of cardiovascular disease, but it is not associated with a statistically significantly increased risk of cardiovascular mortality, according to a study published in the June issue of Clinical Gastroenterology and Hepatology.

(HealthDay) -- Nonalcoholic fatty liver disease (NAFLD) is independently associated with an increased risk of cardiovascular disease (CVD), but it is not associated with a statistically significantly increased risk of cardiovascular mortality, according to a study published in the June issue of Clinical Gastroenterology and Hepatology.

To examine the association between NAFLD, CVD, and , Maria Stepanova, Ph.D., and Zobair M. Younossi, M.D., M.P.H., of Inova Fairfax Hospital in Falls Church, Va., analyzed data from the National Health and Nutrition Survey III (1988 to 1994). The prevalence of CVD was assessed for 2,492 patients with NAFLD and 9,121 controls without NAFLD or other . Independent predictors of CVD and cardiovascular mortality were evaluated.

During a median of 171 months of follow-up, the researchers found cardiovascular mortality in the cohort to be 3.76 percent. Compared to controls, participants with NAFLD were older, predominantly male, less likely to be African-American, and more likely to be Hispanic. Participants with NAFLD had an increased prevalence of all components of CVD and . After adjustment for major demographic, clinical, and metabolic confounders, there was an independent correlation between NAFLD and CVD, regardless of liver enzyme levels (odds ratio, 1.23). There was no statistically significant association found between NAFLD and cardiovascular mortality.

"NAFLD is associated independently with an increased risk of CVD," the authors write. "However, NAFLD did not increase cardiovascular mortality over a 14-year period."

More information: Abstract
Full Text (subscription or payment may be required)
Editorial

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Results of RIBS IV trial reported

7 hours ago

A new clinical trial comparing the use of everolimus-eluting stents (EES) and drug-eluting balloons (DEB) in treating in-stent restenosis (ISR) from drug-eluting stents found that EES provided superior late angiographic results ...

Results of DKCRUSH-VI trial reported

7 hours ago

A new study found that fractional flow reserve (FFR)-guided provisional side branch (SB) stenting of true coronary bifurcation lesions yields similar outcomes to the current standard of care. The DKCRUSH-VI clinical trial ...

Results of IVUS-CTO trial reported at TCT 2014

8 hours ago

A new study found that intravascular ultrasound (IVUS) -guided intervention in patients with chronic total occlusion (CTO) could improve outcomes compared to a conventional angiography-guided approach during percutaneous ...

Results of OCT STEMI trial reported at TCT 2014

8 hours ago

The first randomized trial to examine serial optical coherence tomography (OCT) in primary percutaneous coronary intervention (PCI) was reported at the 26th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific ...

INR variability predicts warfarin adverse effects

13 hours ago

(HealthDay)—Unstable anticoagulation predicts warfarin adverse effects regardless of time in therapeutic range, according to a study published online Sept. 2 in Circulation: Cardiovascular Quality and Ou ...

User comments